Chronic Fatigue Syndrome Market Share Analysis, Suppliers, Properties & Customer Analysis
Chronic Fatigue Syndrome Market Overview: The Chronic Fatigue Syndrome Market Share was USD 115.91 million in 2023 It is projected to reach USD 174.54 Million by 2031 indicating a CAGR of 6.0% during the forecast period. Chronic Fatigue Syndrome Market key drivers: Rising Prevalence: CFS affects millions globally, and increasing awareness is leading to more diagnoses. This fuels the market demand for diagnostic tools and treatment options. Improved Diagnostics: Advancements in diagnostic techniques like blood tests and genetic markers can aid in earlier detection and improved treatment plans, propelling market growth. Growing Focus on Mental Health: CFS often co-occurs with mental health conditions like depression and anxiety. The growing focus on mental health increases investment in research and development of treatments that address both physical and mental aspects of CFS. Chronic Fatigue Syndrome Market Key Players: AIM ImmunoTech, GSK plc., Eisai Co., Ltd...